Soluble immune checkpoints in cancer: production, function and biological significance-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Soluble immune checkpoints in cancer: production, function and biological significance

Published:2018-11-27 Issue:1 Volume:6 Page:
ISSN:2051-1426
Container-title:Journal for ImmunoTherapy of Cancer
language:en
Short-container-title:j. immunotherapy cancer

Author:

Gu Daqian,Ao Xiang,Yang Yu,Chen Zhuo,Xu Xiang^ORCID

Funder

National Natural Science Foundation of China

the Precision Medicine Foundation of Chongqing

the National Key R&D Program

Publisher

BMJ

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1186/s40425-018-0449-0.pdf

Reference113 articles.

1. Sharma P, Allison JP. The future of immune checkpoint therapy. Science. 2015;348:56–61.

2. Buchbinder EI, Desai A. CTLA-4 and PD-1 pathways: similarities, differences, and implications of their inhibition. Am J Clin Oncol. 2016;39:98–106.

3. Menon S, Shin S, Dy G. Advances in Cancer immunotherapy in solid tumors. Cancers. 2016;8.

4. Nielsen C, Ohm-Laursen L, Barington T, Husby S, Lillevang ST. Alternative splice variants of the human PD-1 gene. Cell Immunol. 2005;235:109–16.

5. Oaks MK, Hallett KM, Penwell RT, Stauber EC, Warren SJ, Tector AJ. A native soluble form of CTLA-4. Cell Immunol. 2000;201:144–53.

Cited by 188 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual-signal output biosensor for the detection of program death-ligand 1 and therapy progress monitoring of cancer;Biosensors and Bioelectronics;2024-10

2. Translation element EIF4A1 is a potential divergent immune biomarker between colon cancer and rectal cancer;2024-09-03

3. Patients with peripheral artery disease demonstrate altered expression of soluble and membrane-bound immune checkpoints by peripheral blood immune cells;2024-08-30

4. Peripheral immune biomarkers for immune checkpoint inhibition of solid tumours;Clinical and Translational Medicine;2024-08

5. AURKB promotes immunogenicity and immune infiltration in clear cell renal cell carcinoma;Discover Oncology;2024-07-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3